Spots Global Cancer Trial Database for gej

Every month we try and update this database with for gej cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors	NCT06131840	Colorectal Neop... Carcinoma, Non-... Stomach Neoplas... Pancreatic Duct... Gastroesophagea... Small Cell Lung...	SGN-CEACAM5C	18 Years -	Seagen Inc.
A Beta-only IL-2 ImmunoTherapY Study	NCT05086692	Advanced Solid ... Unresectable So... Clear Cell Rena... Triple Negative... Non-Small Cell ... Non-Small Cell ... Colorectal Canc... Gastric Cancer Cervical Cancer Basal Cell Carc... Bladder Cancer Merkel Cell Car... Squamous Cell C... Cutaneous Squam... Pleural Mesothe... Esophageal Canc... Endometrial Car... Solid Tumor Solid Tumor, Ad... MSI-H Solid Mal... Cancer With A H... Epithelial Ovar... Primary Periton... Gastroesophagea... Acral Melanoma Mucosal Melanom... Cutaneous Melan... DMMR Solid Mali... Fallopian Tube ... Ovarian Cancer MSI-H Cancer DMMR Cancer Pancreas Adenoc... Skin Cancer	MDNA11 Pembrolizumab	18 Years -	Medicenna Therapeutics, Inc.
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma	NCT02138929	Esophageal Canc...	Everolimus LDE 225	18 Years -	M.D. Anderson Cancer Center
IKS014 in Advanced Solid Tumors That Express HER2	NCT05872295	Breast Cancer Gastric Cancer Gastroesophagea...	IKS014	18 Years -	Iksuda Therapeutics Ltd.
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)	NCT03615326	Gastric Neoplas... Gastroesophagea...	Pembrolizumab Placebo Cisplatin 5-FU Oxaliplatin Capecitabine S-1 Trastuzumab	18 Years -	Merck Sharp & Dohme LLC
IKS014 in Advanced Solid Tumors That Express HER2	NCT05872295	Breast Cancer Gastric Cancer Gastroesophagea...	IKS014	18 Years -	Iksuda Therapeutics Ltd.
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)	NCT05002127	Gastric Cancer Gastroesophagea... Gastric Adenoca...	Evorpacept (ALX... Trastuzumab Ramucirumab Paclitaxel	18 Years -	ALX Oncology Inc.
Study of SRF617 in Patients With Advanced Solid Tumors	NCT04336098	Advanced Solid ...	SRF617 Gemcitabine Albumin-Bound P... Pembrolizumab	18 Years -	Surface Oncology
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors	NCT06157892	Breast Neoplasm... Gastroesophagea... HER2 Low Breast... HER2 Positive B... Stomach Neoplas... Triple Negative...	disitamab vedot... tucatinib	18 Years -	Seagen Inc.
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors	NCT06131840	Colorectal Neop... Carcinoma, Non-... Stomach Neoplas... Pancreatic Duct... Gastroesophagea... Small Cell Lung...	SGN-CEACAM5C	18 Years -	Seagen Inc.
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors	NCT06131840	Colorectal Neop... Carcinoma, Non-... Stomach Neoplas... Pancreatic Duct... Gastroesophagea... Small Cell Lung...	SGN-CEACAM5C	18 Years -	Seagen Inc.
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma	NCT02138929	Esophageal Canc...	Everolimus LDE 225	18 Years -	M.D. Anderson Cancer Center
A Study of SGN-B6A in Advanced Solid Tumors	NCT04389632	Carcinoma, Non-... Squamous Cell C... HER2 Negative B... Esophageal Squa... Esophageal Aden... Gastroesophagea... Ovarian Neoplas... Cutaneous Squam... Exocrine Pancre... Urinary Bladder... Uterine Cervica... Stomach Neoplas...	sigvotatug vedo... pembrolizumab cisplatin carboplatin	18 Years -	Seagen Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world:

Spots Global Cancer Trial Database for gej

Every month we try and update this database with for gej cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for gej cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.